Marie-Thérèse Leccia
Marie-Thérèse Leccia is an expert in Dermatology at Centre Hospitalier Universitaire de Grenoble (France). As of September 2026, ScienceLeadR ranks Marie-Thérèse Leccia in the top 1% of experts worldwide for Skin Neoplasms and Melanoma. Marie-Thérèse Leccia has authored 418 publications, the most recent in 2026, and is an investigator in 14 clinical trials. SLR score: 1,002 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Oncology - Neurology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 418
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study. PMID 42791653 — cells, merkel cells, somatostatin, neoplasms, therapeutics, dermatology, carcinoma, merkel cell | Cancer Med | 2026 | 0 |
| Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. PMID 42090793 — skin, ivermectin, absenteeism, permethrin, scabies, therapeutics | N Engl J Med Top journal | 2026 | 0 |
| Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas. PMID 41277783 — sexually transmitted diseases, melanoma, foot, skin diseases, immunotherapy, drug-related side effects and adverse reactions, immune checkpoint inhibitors, neoplasm metastasis, chemotherapy, adjuvant, nivolumab, therapeutics | J Eur Acad Dermatol Venereol | 2025 | 0 |
| Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel). PMID 40912206 — sexually transmitted diseases, lymph nodes, melanoma, retrospective studies, covid-19, lymph, diagnosis, pandemics, therapeutics, dermatology | Ann Dermatol Venereol | 2025 | 0 |
| Acquired cutaneous pseudoxanthoma elasticum progressing after chronic liver transplant rejection. PMID 40876304 — graft rejection, sexually transmitted diseases, liver transplantation, pseudoxanthoma elasticum, liver, transplants, dermatology | Ann Dermatol Venereol | 2025 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map